Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Monte Rosa Therapeutics, Inc. Common Stock | GLUE

AI Analysis of Monte Rosa Therapeutics, Inc. Common Stock

Monte Rosa Therapeutics is down a bit on the day, funds flowing out kept the price down -1.09% since yesterday.

Monte Rosa Therapeutics doesn't seem to be at a very clear reversal point in either direction. Monte Rosa Therapeutics has been drifting up over the last few months, we'll see if it has the energy to keep moving in the right direction. It may find some support around the $19.74 price level in the near term.


Last analyzed on 2026-07-23

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-